Literature DB >> 27235695

Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among Women.

Monik C Jiménez1, Kathryn M Rexrode2, Gregory Kotler2, Brendan M Everett2, Robert J Glynn3, I-Min Lee4, Julie E Buring4, Paul M Ridker2, Howard D Sesso5.   

Abstract

BACKGROUND: Markers of systemic inflammation (high-sensitivity C-reactive protein [hsCRP], soluble intercellular adhesion molecule 1 [sICAM-1], and fibrinogen) have been associated with a greater risk of total and ischemic stroke, in addition to elevated blood pressure. However, the role of these inflammatory markers on stroke pathophysiology by hypertension status is uncertain.
METHODS: Blood samples were collected and assayed for hsCRP, sICAM-1, and fibrinogen among 27,330 initially healthy women from the Women's Health Study, and women were followed up from 1992 to 2013. Prior to randomization, the baseline questionnaire collected self-reported hypertension status, cardiovascular risk factors, and lifestyle factors. New cases of total, ischemic, and hemorrhagic stroke were updated annually through questionnaires and confirmed by medical records according to the National Survey of Stroke criteria. Multivariable Cox models estimated overall associations between each inflammatory marker and stroke and separately stratified by hypertension status.
RESULTS: We observed 629 incident total strokes over 477,278 person-years. In adjusted analyses, extreme quartiles of hsCRP and sICAM-1 were each associated with a significantly greater risk of total stroke (hsCRP: hazard ratios [HR] = 1.77, 95% confidence interval [CI]: 1.39-2.26; sICAM-1: HR = 1.28, 95% CI: 1.00-1.63). Fibrinogen was not associated with a significantly greater stroke risk. In analyses stratified by hypertension status, elevated hsCRP was associated with a nonstatistically significant greater risk of total stroke among prehypertensive and hypertensive women.
CONCLUSIONS: These data indicate that hsCRP and sICAM-1 are associated with hypertension status and stroke risk among women. Further work should examine the role of inflammatory markers on ischemic stroke subtypes and clarify mechanisms. © American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; fibrinogen; high-sensitivity C-reactive protein; hypertension; intercellular adhesion molecule 1; ischemic stroke; prehypertension.

Mesh：

Substances：

Year:  2016        PMID： 27235695      PMCID： PMC4978228          DOI： 10.1093/ajh/hpw050

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN： 0895-7061            Impact factor:   2.689


  28 in total

1.  Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.

Authors:  David Tanne; Moti Haim; Valentina Boyko; Uri Goldbourt; Tamar Reshef; Shlomo Matetzky; Yehuda Adler; Yoseph A Mekori; Solomon Behar
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

2.  Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.

Authors:  Samia Mora; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2006-07-24       Impact factor: 29.690

3.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

4.  The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.

Authors:  Brendan M Everett; Tobias Kurth; Julie E Buring; Paul M Ridker
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

5.  Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

Authors:  Paul M Ridker; Nader Rifai; Nancy R Cook; Gary Bradwin; Julie E Buring
Journal:  JAMA       Date:  2005-07-20       Impact factor: 56.272

6.  Uric acid and insulin sensitivity and risk of incident hypertension.

Authors:  John P Forman; Hyon Choi; Gary C Curhan
Journal:  Arch Intern Med       Date:  2009-01-26

7.  Reproducibility and validity of self-reported menopausal status in a prospective cohort study.

Authors:  G A Colditz; M J Stampfer; W C Willett; W B Stason; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

8.  Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study.

Authors:  Michelle A Albert; Robert J Glynn; Julie E Buring; Paul M Ridker
Journal:  Atherosclerosis       Date:  2007-07-20       Impact factor: 5.162

9.  Alcohol consumption and the risk of hypertension in women and men.

Authors:  Howard D Sesso; Nancy R Cook; Julie E Buring; JoAnn E Manson; J Michael Gaziano
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

Review 10.  Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.

Authors:  Thijs C van Holten; Leonie F Waanders; Philip G de Groot; Joost Vissers; Imo E Hoefer; Gerard Pasterkamp; Menno W J Prins; Mark Roest
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240
View more
  6 in total

Review 1.  Cardiovascular Risk in Patients with Prehypertension and the Metabolic Syndrome.

Authors:  Sergey Kachur; Rebecca Morera; Alban De Schutter; Carl J Lavie
Journal:  Curr Hypertens Rep       Date:  2018-03-06       Impact factor: 5.369

2.  Increased serum exosomal miR-134 expression in the acute ischemic stroke patients.

Authors:  Jingxia Zhou; Lin Chen; Bocan Chen; Shaozhu Huang; Chaosheng Zeng; Hairong Wu; Cong Chen; Faqing Long
Journal:  BMC Neurol       Date:  2018-12-04       Impact factor: 2.474

3.  Identification of the key genes and immune infiltrating cells determined by sex differences in ischaemic stroke through co-expression network module.

Authors:  Haipeng Xu; Yanzhi Ge; Yang Liu; Yang Zheng; Rong Hu; Conglin Ren; Qianqian Liu
Journal:  IET Syst Biol       Date:  2021-11-18       Impact factor: 1.615

4.  Salt-Sensitive Hypertension Induces Osteoclastogenesis and Bone Resorption via Upregulation of Angiotensin II Type 1 Receptor Expression in Osteoblasts.

Authors:  Adya Pramusita; Hideki Kitaura; Fumitoshi Ohori; Takahiro Noguchi; Aseel Marahleh; Yasuhiko Nara; Ria Kinjo; Jinghan Ma; Kayoko Kanou; Yukinori Tanaka; Itaru Mizoguchi
Journal:  Front Cell Dev Biol       Date:  2022-04-04

5.  Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke.

Authors:  Núria Puig; Pol Camps-Renom; Mercedes Camacho; Ana Aguilera-Simón; Francesc Jiménez-Altayó; Alejandro Fernández-León; Rebeca Marín; Joan Martí-Fàbregas; Jose Luis Sánchez-Quesada; Elena Jiménez-Xarrié; Sonia Benitez
Journal:  Transl Stroke Res       Date:  2022-03-02       Impact factor: 6.800

6.  Adjunctive Chinese Herbal Products Therapy Reduces the Risk of Ischemic Stroke Among Patients With Rheumatoid Arthritis.

Authors:  Hsuan-Shu Shen; Jen-Huai Chiang; Nai-Huan Hsiung
Journal:  Front Pharmacol       Date:  2020-03-04       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.